Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Natural Killer Cell Selected T-cell Depleted Donor Lymphocyte Infusions (NK-DLI) in Patients After HLA-haploidentical Allogeneic Stem Cell Transplantation

NCT01386619 is registered in ClinicalTrials.gov with University Hospital, Basel, Switzerland as lead sponsor.

NCT NCT01386619
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01386619 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Natural Killer Cell Selected T-cell Depleted Donor Lymphocyte Infusions (NK-DLI) in Patients After HLA-haploidentical Allogeneic Stem Cell Transplantation
Lead sponsor
University Hospital, Basel, Switzerland
Phase
Phase 1/2
Overall status
Completed
Start date
January 31, 2004
Completion date
March 31, 2011
Enrollment
15 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia, myeloid, acute, lymphoma, myelodysplastic syndromes, neuroblastoma, precursor cell lymphoblastic leukemia-lymphoma, rhabdomyosarcoma